Endocrinology, 112(5), 1613-1617
Rapid early loss isnt required for long-term success, and slower, steady loss is common and normal
Over the past decade, weve worked with dozens of companies in the industry to understand their supplier portfolios, help them identify market risks, and adapt their strategies to avoid disruption
SD rats were randomly assigned into five groups: the non-treatment control group, the streptozotocin (STZ)-induced T2DM group, the STZ-induced T2DM plus sham surgery group, the STZ-induced T2DM plus RYGB surgery group, and the STZ-induced T2DM plus EX-4 treatment group
Formats: vials, cartridges, and SoloStar pens
The Lancet Diabetes & Endocrinology, 5(4), 251-260